{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:32:19Z","timestamp":1720675939432},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.lpm.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T17:46:04Z","timestamp":1401903964000},"page":"e143-e150","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Where is lupus hidden?"],"prefix":"10.1016","volume":"43","author":[{"given":"Falk","family":"Hiepe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.04.005_bib0005","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1981.03310340024021","article-title":"Systemic lupus erythematosus\u00a0\u2013\u00a0survival patterns. Experience with 609 patients","volume":"245","author":"Wallace","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.04.005_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(91)90057-7","article-title":"Lupus erythematosus in the 1980s: a survey of 570 patients","volume":"21","author":"Pistiner","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am J med"},{"key":"10.1016\/j.lpm.2014.04.005_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/0961203310370048","article-title":"Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates","volume":"19","author":"Obermoser","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.04.005_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181632d18","article-title":"Jaccoud arthropathy in systemic lupus erythematosus: analysis of clinical characteristics and review of the literature","volume":"87","author":"Santiago","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2014.04.005_bib0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2012.09.004","article-title":"Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients","volume":"12","author":"Tani","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2014.04.005_bib0040","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/ar2036","article-title":"Presence of antibodies against cyclic citrullinated peptides in patients with \u201crhupus\u201d: a cross-sectional study","volume":"8","author":"Amezcua-Guerra","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.04.005_bib0045","first-page":"2226","article-title":"Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus","volume":"28","author":"Gladman","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0050","first-page":"761","article-title":"Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus","volume":"28","author":"Gladman","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/RHU.0b013e31819dbd20","article-title":"Osteonecrosis and antiphospholipid syndrome","volume":"15","author":"Rueda","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1191\/0961203305lu2146rr","article-title":"Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome","volume":"14","author":"Vasoo","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.04.005_bib0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.crad.2012.06.109","article-title":"Imaging of systemic lupus erythematosus. Part II: gastrointestinal, renal, and musculoskeletal manifestations","volume":"68","author":"Goh","year":"2013","journal-title":"Clin Radiol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"Nomenclature Aahconl. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0075","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0027-9684(15)31245-1","article-title":"Recurrent headache and MRI findings in systemic lupus erythematosus","volume":"100","author":"Bicakci","year":"2008","journal-title":"J Nat Med Assoc"},{"key":"10.1016\/j.lpm.2014.04.005_bib0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1191\/0961203303lu506oa","article-title":"Headache and systemic lupus erythematosus","volume":"12","author":"Cuadrado","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.04.005_bib0095","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/brain\/awh146","article-title":"A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth","volume":"127","author":"Mitsikostas","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2014.04.005_bib0100","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3899\/jrheum.101308","article-title":"Posterior reversible encephalopathy syndrome in systemic lupus erythematosus","volume":"38","author":"Varaprasad","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0110","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.04.005_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2014.04.005_bib0120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2014.04.005_bib0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/art.27337","article-title":"Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome","volume":"62","author":"Wandinger","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0130","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0135","first-page":"1699","article-title":"Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support","volume":"32","author":"Jump","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","article-title":"Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus","volume":"27","author":"Schmeding","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.lpm.2014.04.005_bib0155","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2014.04.005_bib0165","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","article-title":"High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis","volume":"21","author":"Trendelenburg","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2014.04.005_bib0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/ard.52.12.851","article-title":"Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus","volume":"52","author":"Siegert","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0175","doi-asserted-by":"crossref","first-page":"c355","DOI":"10.1159\/000323388","article-title":"Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus","volume":"118","author":"Moura","year":"2011","journal-title":"Nephron Clin Prac"},{"key":"10.1016\/j.lpm.2014.04.005_bib0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1529-0131(199901)42:1<187::AID-ANR24>3.0.CO;2-U","article-title":"Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients","volume":"42","author":"Trendelenburg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203311411597","article-title":"Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers","volume":"20","author":"Akhter","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.04.005_bib0190","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2008.094508","article-title":"Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis","volume":"68","author":"Moroni","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1681\/ASN.2004080658","article-title":"Urine chemokines as biomarkers of human systemic lupus erythematosus activity","volume":"16","author":"Rovin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis","volume":"49","author":"Rubinstein","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.04.005_bib0205","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar2816","article-title":"Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study","volume":"11","author":"Schwartz","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.04.005_bib0210","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/rheumatology\/kel351","article-title":"Urinary proteomic profiles distinguish between active and inactive lupus nephritis","volume":"45","author":"Mosley","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.04.005_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/annrheumdis-2012-202784","article-title":"Urinary CD4T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response","volume":"73","author":"Enghard","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000024424","article-title":"Significance of autoantibodies in neonatal lupus erythematosus","volume":"123","author":"D\u00f6rner","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0225","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Col Cardiol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0230","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2014.04.005_bib0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ncprheum1018","article-title":"Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside","volume":"5","author":"Buyon","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0245","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.04.005_bib0250","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2014.04.005_bib0255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2014.04.005_bib0260","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000117824","article-title":"Direct assessment of thymic reactivation after autologous stem cell transplantation","volume":"119","author":"Thiel","year":"2008","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.lpm.2014.04.005_bib0265","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2012-202216","article-title":"Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0270","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0275","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.04.005_bib0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1546-0096-10-21","article-title":"Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis","volume":"10","author":"Belot","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.lpm.2014.04.005_bib0285","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.04.005_bib0290","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1172\/JCI63835","article-title":"Theofilopoulos AN. TLRs and IFNs: critical pieces of the autoimmunity puzzle","volume":"122","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2014.04.005_bib0295","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0300","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"R\u00f6nnblom","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smim.2011.01.009","article-title":"The type I interferon system in the development of lupus","volume":"23","author":"R\u00f6nnblom","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0310","first-page":"359","article-title":"Type I interferon in systemic lupus erythematosus","volume":"316","author":"Crow","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0315","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lpm.2014.04.005_bib0320","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2014.04.005_bib0325","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0330","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/art.23404","article-title":"Sialic acid-binding Ig-like lectin I expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus","volume":"58","author":"Biesen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0335","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1136\/annrheumdis-2012-201586","article-title":"IFNalpha and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus","volume":"72","author":"Rose","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0340","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.04.005_bib0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.immunol.24.021605.090517","article-title":"B cell immunobiology in disease: evolving concepts from the clinic","volume":"24","author":"Martin","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/40540","article-title":"Lifetime of plasma cells in the bone marrow","volume":"388","author":"Manz","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2014.04.005_bib0355","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.lpm.2014.04.005_bib0360","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.23.021704.115723","article-title":"Maintenance of serum antibody levels","volume":"23","author":"Manz","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0365","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0370","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2014.04.005_bib0375","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1136\/annrheumdis-2013-203455","article-title":"Autoantibodies from long-lived \u201cmemory\u201d plasma cells of NZB\/W mice drive immune complex nephritis","volume":"72","author":"Cheng","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaut.2012.05.010","article-title":"Bone marrow of NZB\/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity","volume":"39","author":"Mumtaz","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.lpm.2014.04.005_bib0385","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2014.04.005_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/ard.2008.096495","article-title":"HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus","volume":"69","author":"Jacobi","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.04.005_bib0395","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T16:57:37Z","timestamp":1538585857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0755498214002127"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Where is lupus hidden?","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}